Altimmune, Inc. (ALT) on Thursday said that its mid-stage study of Pemvidutide in metabolic dysfunction-associated ...

Madrigal Pharma's REZDIFFRA sees 33% Q1 2025 sales growth, strong EU progress, and promising MASH data. Read why I maintain ...

She continued, "Unfortunately, in my case, it did detect some spots on my liver that were a little suspicious. Because of this, I did have to then do a liver biopsy to see if my cancer has spread." ...

During the 1990s, there was a revolution in the way that pathologists and hepatologists thought about chronic viral hepatitis. This revolution was stimulated by the realization that the ...

Abstract. Objective: To evaluate variables affecting the need for analgesia after ultrasound-guided percutaneous liver biopsy performed on an outpatient basis. Materials and Methods: This was a ...

Liver biopsy position. Unless the doctor says otherwise, they’ll ask you to lie on your back with your right hand under your head and your elbow out to your side. ...

Data regarding risk factors and long-term outcomes of U.S. patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. This study aimed to investigate ...

Preliminary Phase 2 results show 83% of those treated with Boehringer Ingelheim and Zealand Pharma drug survodutide met the main goal of improvement in the fatty liver disease MASH. Boehringer ...

A Binding LOI has been executed: GEDiCube will acquire 75% of Cyclomics at Closing.Expected breakthroughs by combining technologies in (early) cancer detection and recurrence of cancer with a single ...